Literature DB >> 32335706

CT, [18F]FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour.

Margarita Kirienko1, Barbara Padovano2, Gianluca Serafini2, Alfonso Marchianò3, Alessandro Gronchi4, Ettore Seregni2, Alessandra Alessi2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32335706      PMCID: PMC7183390          DOI: 10.1007/s00259-020-04822-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
The incidence of Covid-19 is rapidly growing worldwide. In Italy, as of April 3,, 119,827 cases have been reported with a toll death of 14,681 [1]; in Lombardy, the number of cases was 47,520, with 8311 deaths [2]. Early identification of SARS-CoV-2 infection is important for the safety of patients and health workers. Imaging can play a role in the diagnosis of Covid-19 [3, 4]. A 73-year-old male from Bergamo (Italy) was admitted to the National Cancer Institute of Milan, for curative surgery of a 22.5 × 14.2 × 19 cm vascular tumour, intermediate risk, of the right retroperitoneum. At admission, he was asymptomatic, and during hospitalization, he progressively developed fever (up to 38 °C) and hypoxemia. Temporal track of clinical data, laboratory tests and imaging findings (both computed tomography (CT) and [18F]fluoro-deoxyglucose ([18F]FDG) positron emission tomography (PET)/CT), retrospectively retrieved, are reported in the Figure. Imaging suggested viral infection. Diagnosis was obtained by means of reverse transcription polymerase chain reaction on rhino pharyngeal swab. Subsequently, the patient was transferred to a Covid-19 dedicated hospital; surgery was postponed. We could not reach the patient for consent; local ethics committee approved the publication. Epidemiological data, worldwide and at local level, need to be considered when approaching a patient with respiratory symptoms. Neoplastic disease may constitute a risk factor and also a confounding factor. It is important to recognize Covid-19 as early as possible for optimal patient management and ensure hospital staff and patient’s safety. Imaging demonstrated Covid-19 even in the presence of mild symptoms. In view of its high sensitivity, imaging may be considered for anticipating diagnosis and safety interventions. Early after image acquisition, scans should be reviewed to identify suspected Covid-19 cases. High-resolution CT of the thorax during PET acquisition could improve lung abnormalities detection.
  2 in total

1.  Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.

Authors:  Xi Xu; Chengcheng Yu; Jing Qu; Lieguang Zhang; Songfeng Jiang; Deyang Huang; Bihua Chen; Zhiping Zhang; Wanhua Guan; Zhoukun Ling; Rui Jiang; Tianli Hu; Yan Ding; Lin Lin; Qingxin Gan; Liangping Luo; Xiaoping Tang; Jinxin Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-28       Impact factor: 9.236

2.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases.

Authors:  Chunxia Qin; Fang Liu; Tzu-Chen Yen; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-22       Impact factor: 9.236

  2 in total
  4 in total

Review 1.  Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.

Authors:  Ryogo Minamimoto; Tomomichi Kiyomatsu
Journal:  Glob Health Med       Date:  2021-06-30

Review 2.  FDG-PET/CT images of COVID-19: a comprehensive review.

Authors:  Ryogo Minamimoto; Masatoshi Hotta; Masahiro Ishikane; Takeshi Inagaki
Journal:  Glob Health Med       Date:  2020-08-31

3.  FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective.

Authors:  Simone Maurea; Ciro Gabriele Mainolfi; Claudia Bombace; Alessandra Annunziata; Ludovica Attanasio; Mario Petretta; Silvana Del Vecchio; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-23       Impact factor: 10.057

4.  A twisted tale-radiological imaging features of COVID-19 on 18F-FDG PET/CT.

Authors:  Hazel O'Neill; Simon Doran; Francesco Fraioli; Afshin Nasoodi
Journal:  Eur J Hybrid Imaging       Date:  2020-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.